Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells.
CK2 is a pleiotropic protein kinase, which regulates many survival pathways and plays a global anti-apoptotic function. It is highly expressed in tumor cells, and is presently considered a promising therapeutic target. Among the many inhibitors available for this kinase, the recently developed CX-49...
Guardado en:
Autores principales: | Sofia Zanin, Christian Borgo, Cristina Girardi, Sean E O'Brien, Yoshihiko Miyata, Lorenzo A Pinna, Arianna Donella-Deana, Maria Ruzzene |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1628c93d81e54239a1197f03df0b6790 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
por: Michihito Sato, et al.
Publicado: (2011) -
CxNy: New Carbon Nitride Organic Photocatalysts
por: Nieves López-Salas, et al.
Publicado: (2021) -
Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure
por: M. Flamant, et al.
Publicado: (2021) -
The potential antiepileptogenic effect of neuronal Cx36 gap junction channel blockage
por: Wang Guangliang, et al.
Publicado: (2021) -
Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization.
por: Arun H S Kumar, et al.
Publicado: (2013)